Edwards Lifesciences International — Carryforward amount decreased by 100.0% to $0.00 in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $6.00M to $0.00.
An increase may indicate higher deferred revenue or tax assets, while a decrease suggests the realization of previously deferred items or changes in regional accounting estimates.
This metric represents the deferred or carryforward financial balance associated with the International geographic segme...
Similar to deferred revenue or tax carryforward balances reported by other multinational medical device firms with significant non-domestic revenue streams.
ew_segment_international_carryforward_amount| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $2.90M | $4.30M | $700.00K | $6.00M | $0.00 |
| QoQ Change | — | +48.3% | -83.7% | +757.1% | -100.0% |
| YoY Change | — | +48.3% | -83.7% | +757.1% | -100.0% |